Literature DB >> 18830829

Prostate-specific antigen in the cerebrospinal fluid: a marker of local disease.

George Orphanos1, George Ioannidis, Michael Michael, George Kitrou.   

Abstract

Leptomeningeal involvement from prostate cancer is a rare complication with dismal prognosis. Prostate-specific antigen in the cerebrospinal fluid may be found elevated and can be used as a marker for local disease. We present the case of a patient with prostate cancer and leptomeningeal metastases who had high levels of prostate-specific antigen in the cerebrospinal fluid.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18830829     DOI： 10.1007/s12032-008-9096-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  13 in total

1.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

2.  Cerebrospinal fluid prostate specific antigen (CSF PSA) in prostate cancer patients with lower spine metastasis.

Authors:  Hayrettin Sahin; Uğur Aflay; Sabri Batun; Mehmet Kamuran Bircan
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain.

Authors:  M C Chamberlain; A D Sandy; G A Press
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

4.  Behavior of prostatic specific antigen (PSA) in spinal fluid: its correlation with serum levels.

Authors:  J Morote; A Ruibal; M Boada
Journal:  Int J Biol Markers       Date:  1986 May-Aug       Impact factor: 2.659

Review 5.  Neurologic complications of prostate cancer.

Authors:  Ramsis Benjamin
Journal:  Am Fam Physician       Date:  2002-05-01       Impact factor: 3.292

6.  Leptomeningeal carcinomatosis in a patient with metastatic prostate cancer: case report and literature review.

Authors:  Lawrence A Cone; Kamran Koochek; Helene A Henager; Richard Fausel; Radhika Gade-Andavolu; Barbara E Potts; Lela M Jennings
Journal:  Surg Neurol       Date:  2006-04

Review 7.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

8.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

9.  Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients.

Authors:  M Camerlingo; R Nemni; B Ferraro; L Casto; T Partziguian; B Censori; A Mamoli
Journal:  Arch Neurol       Date:  1998-07

Review 10.  Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: a unique case report and review of the literature.

Authors:  B Schaller; A Merlo; E Kirsch; K Lehmann; P R Huber; P Lyrer; A J Steck; O Gratzl
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
View more
  3 in total

Review 1.  Leptomeningeal metastases from prostate cancer: an emerging clinical conundrum.

Authors:  George Orphanos; Alexandros Ardavanis
Journal:  Clin Exp Metastasis       Date:  2009-11-11       Impact factor: 5.150

2.  Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.

Authors:  Yue Zhao; Jun-Ying He; Yue-Li Zou; Xiao-Su Guo; Jun-Zhao Cui; Li Guo; Hui Bu
Journal:  BMC Neurol       Date:  2019-12-19       Impact factor: 2.474

3.  Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy.

Authors:  Neil Chevli; Amarinthia E Curtis; Suzanne Powell; Pamela New; E Brian Butler; Bin S Teh
Journal:  Adv Radiat Oncol       Date:  2021-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.